Kezar Life Sciences logo

Kezar Life Sciences

KZR | NASDAQ
Chart Builder DCF Calculator
$7.29
$0.00 (0.00%)
At close: May 8, 2026, 4:00 PM ET
+0.00%

Rating

Updated: Sep 30, 2026
24.8
+9.8 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $53.86M
1D Range
7.29 7.29
52W Range
3.53 7.55

Valuation (TTM)

PE -1.18
PB 0.83
EV/EBITDA 0.35

Valuation (NTM)

Forward PE N/A
Forward PEG 0.04
Price Target $11.00
Loading financial charts...

Profile

Kezar Life Sciences, Inc. is a United States-based clinical-stage biopharmaceutical company focused on identifying and advancing novel small molecule therapies. Its mission is to address significant u...

Sector Healthcare
Industry Biotechnology
Employees 55
IPO Date Jun 21, 2018
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
3
Consensus
Hold
Price Target
$7.00
Downside
-3.98%
Buy (0)
Hold (2)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.